Creo Medical Regulatory News (CREO)

(a) name of the company;

China Real Estate Opportunities plc

(b) name of the scheme;

Share option scheme

(c) period of return (from/to);

1 July 2009 to 31 December 2009

(d) number and class of securities not issued under the scheme;

1,971,200 ordinary shares of no par value

(e) number of securities issued under the scheme during the period;

none

(f) balance under the scheme of securities not yet issued at the end of the period;

1,971,200 ordinary shares of no par value

(g) number and class of securities originally admitted and the date of admission;

2,000,000 ordinary shares of no par value, 3 July 2008

(h) a contact name and telephone number.

Sarah Moriarty

CREO - Investor relations

+ 353 1 618 9455